Understanding and Managing Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Advanced Melanoma

The immune checkpoint inhibitors ipilimumab, nivolumab, and pembrolizumab represent a substantial improvement in treating advanced melanoma but are associated with adverse events (AEs) likely related to general immunologic enhancement. To ensure that patients receive optimal benefit from these agent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Adv Pract Oncol
Main Authors: Weinstein, Alyona, Gordon, Ruth-Ann, Kasler, Mary Kate, Burke, Matthew, Ranjan, Smita, Hodgetts, Jackie, Reed, Vanessa, Shames, Yelena, Prempeh-Keteku, Nana, Lingard, Karla
Formato: Artigo
Idioma:Inglês
Publicado em: Harborside Press 2017
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995532/
https://ncbi.nlm.nih.gov/pubmed/29900017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados